CORE B The proposed Center for Excellence in Translational Research combines four projects focused on developing a rapid molecular diagnostic to detect altered drug responses to Mycobacteria tuberculosis (Mtb). Core B, our proposed clinical research core, will support projects involving human subjects. We will build on systems and expertise that we have developed in previous work to provide services that include developing protocols to ensure all aspects of human subjects research meet NIH requirements; that all procedures and materials are in place for data management, quality control, storage and analysis; that data collection protocols are being implemented; that staff are trained in the research and understand its goals; and that specimen collection and clinical procedures are standard across sites.

Public Health Relevance

CORE B By supporting human subjects research including data collection and analysis of this CETR, Core B will contribute to the development of a rapid molecular diagnostic to detect altered drug responses to Mtb and enable early diagnosis and appropriate treatment of drug-resistant TB.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI142793-01
Application #
9676924
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Harvard Medical School
Department
Type
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115